Stifel on X4 Pharmaceuticals (XFOR): 'today’s disclosure significantly de-risks the now enrolling P3 4WARD trial'

Go back to Stifel on X4 Pharmaceuticals (XFOR): 'today’s disclosure significantly de-risks the now enrolling P3 4WARD trial'
(NASDAQ: XFOR) Delayed: 4.22 -0.07 (1.63%)
Previous Close $4.29    52 Week High
Open $4.26    52 Week Low
Day High $4.33    P/E N/A 
Day Low $4.05    EPS
Volume 840,932